In a grim reality, from 2021 till July 2025, clinical trials in India have seen 1,705 deaths and more than 7,000 serious adverse events, equivalent to one participant dying and four others suffering life-threatening complications every single day, according to data released by the Central Drugs Standard Control Organisation (CDSCO) through an RTI response.
This information was provided by CDSCO in response to an RTI query, which had sought SAE-related data for Hyderabad and Telangana. Instead, the regulator shared nationwide figures.
The CDSCO’s reply, accessed through an RTI application, shows that between 2021 and July 2025, 1,705 participants died due to Serious Adverse Events (SAEs) during clinical trials across the country. In the same period, 7,189 cases of non-fatal SAEs were recorded—an average of 4.2 people every day experiencing life-threatening side effects.
For more details, check out the full story on the link mentioned below:
One Death a Day: 1,705 Lives Lost in India's Clinical Trials Since 2021, RTI Reveals
Paediatrician ordered to pay Rs 7.5 Lakh Compensation for 4-year-old's death
The District Consumer Disputes Redressal Commission has directed a Sangli-based paediatrician to pay Rs 7.5 lakh compensation to the mother of a four-year-old girl, who died after treatment.
While considering the complaint filed by the patient's mother, the District Consumer Court ruled that the treating doctor provided 'deficient service' as necessary tests were not performed before beginning treatment.
It was alleged that the symptoms indicated dengue or malaria. However, the concerned doctor did not carry out the required tests even though the laboratories were available in the town.
For more details, check out the full story on the link mentioned below:
Paediatrician Ordered to Pay Rs 7.5 Lakh Compensation for 4-year-old's death
Nita Ambani Unveils 2,000-Bed Medical City with AI Innovations in Mumbai
In a major step to transform the country’s healthcare landscape, Nita Ambani, Founder and Chairperson of Reliance Foundation, announced the establishment of a massive state-of-the-art 2,000-bed medical city in Mumbai.
The facility will not just be another hospital, but a hub of healthcare innovation where advanced medical technology and artificial intelligence will work alongside some of the world’s finest doctors to provide world-class treatment at affordable costs. This initiative is set to revolutionise the health and medical industry, restructuring and reshaping it with the power of advanced technology to serve humankind better.
For more details, check out the full story on the link below:
New hope for healthcare: Nita Ambani announces 2000-bed Medical City in Mumbai
KMC Manipal unveils India's First Department of AI in Healthcare
Kasturba Medical College, Manipal, part of Manipal Academy of Higher Education (MAHE), launched what it claims is India's first Department of Artificial Intelligence (AI) in Healthcare on Friday, marking a milestone in the country's medical education.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.